Search

everythinglearnresearchcommunity

for

Search:↓

BMD-1141 effectively regrows hair in alopecia areata with less frequent dosing than current treatments.

Changing protein kinase levels in pituitary cells affects calcium flow and beta-endorphin release.

Baricitinib effectively improved skin and hair conditions in a patient with alopecia areata and atopic dermatitis.

The man was diagnosed with stage III multiple myeloma and treated to improve kidney function.

Abrocitinib, a JAK inhibitor, may help treat atopic dermatitis and alopecia universalis together.

HDAC inhibitors help brain cells grow and improve brain function.

NKIRAS2 can suppress certain skin tumors but its effect on cancer varies with context and expression level.

Potential compounds may inhibit hair loss by targeting a non-androgen pathway.

Tofacitinib improved hair loss and skin symptoms in a patient after secukinumab caused hair loss.

Certain Dibenzo derivatives may help treat prostate cancer.

Deuruxolitinib is approved to treat severe alopecia areata in adults.

Imatinib can cause hair loss due to lichen planopilaris.

Tofacitinib helped psoriasis but not alopecia universalis, needing more research.

Metabolite 7 is a strong inhibitor for Alzheimer's disease management.

Finasteride may help treat kidney disease caused by a high-fat diet by reducing harmful toxins and improving gut bacteria.

Combining Ficlatuzumab and Gefitinib can cause severe hair loss.

Combining doxazosin and finasteride is more effective for managing benign prostatic hyperplasia than using either drug alone.

Some small molecule antivirals show promise against COVID-19, but more research is needed to understand and improve them.

Triple Hormonal Blockade (ADT3) can effectively manage prostate cancer but requires careful monitoring for heart risks.

JAK inhibitors are effective for hair regrowth in severe alopecia areata.

Blocking CYP17A1 enzyme may help improve certain brain function issues related to dopamine.

Proper ischemic stroke treatment with a multidisciplinary approach reduces mortality and morbidity.

Shikonin, a small molecule, speeds up skin wound healing in mice.

The current system can't fully test all combination treatments, so alternative methods and regulatory flexibility are needed.

KATP channels are crucial for hair growth, and targeting them may lead to new hair loss treatments.

CEP135 may predict cancer outcomes, and targeting PLK1 could help treat certain sarcomas.

Oral difelikefalin significantly reduces itch in notalgia paresthetica.

Gemcitabine and Disitamab Vedotin effectively and safely reduced bladder cancer in a patient.

A new treatment using nanoliposomes can improve hair regrowth in androgenetic alopecia.